医学
耐受性
类风湿性关节炎
药理学
生物等效性
不利影响
内科学
药代动力学
作者
David E. Yocum,S. Allard,Stanley Cohen,P. Emery,R.M. Flipo,J E Goobar,Shyamalie Jayawardena,C Job-Deslandre,R. W. Jubb,K. Krüger,A Lopes Vaz,B. Manger,Erich Mur,Halvor Nygaard,Stefan M. Weiner,Franz Rainer,Marshall Sack,M. Schiff,Thomas J. Schnitzer,Laura Trigg,I. Whatmough,Anja Schmidt
出处
期刊：Rheumatology
[Oxford University Press]
日期：2000-02-01
卷期号：39 (2): 156-164
被引量：18
标识
DOI：10.1093/rheumatology/39.2.156
摘要
Objective. To compare the safety, tolerability and efficacy of the new oral microemulsion formulation of cyclosporin A (CyA; Sandimmun Neoral®) and the original CyA formulation (Sandimmun®), in patients with severe active rheumatoid arthritis (RA), over a 12‐month period.
科研通智能强力驱动
Strongly Powered by AbleSci AI
我是站长才怪
Yoanna_UTHSC
tuanheqi
帅气的如豹
qq1083716237
橘海万青
梁朝伟
简单从丹
Hayat
大佬
VDC
kalah
07
爱静静
丘比特
yizhilaohuli
持卿
wax
jyy
充电宝
皖公网安备34019202002308
